Original Research
Published on 12 Jun 2024
Human antibodies neutralizing the alpha-latrotoxin of the European black widow
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1407398
- 3,630 views
Type at least 3 characters
2,747 articles
Articles
Original Research
Published on 12 Jun 2024
Human monoclonal antibodies protect against viral-mediated pneumococcal superinfection
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1364622
- 1,390 views
Original Research
Published on 11 Jun 2024
PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1415834
- 1,268 views
Original Research
Published on 10 Jun 2024
Increased efficacy of influenza virus vaccine candidate through display of recombinant neuraminidase on virus like particles
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1425842
- 2,050 views
- 1 citation
Original Research
Published on 07 Jun 2024
The cytoskeletal protein profilin is an important allergen in saltwort (Salsola kali)
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1379833
- 1,459 views
Original Research
Published on 07 Jun 2024
Deletion of an immune evasion gene, steD, from a live Salmonella enterica serovar Typhimurium vaccine improves vaccine responses in aged mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1376734
- 1,185 views
Clinical Trial
Published on 06 Jun 2024
Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trial
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1407826
- 1,845 views
- 1 citation
Original Research
Published on 06 Jun 2024
MAVS disruption impairs downstream signaling and results in higher virus replication levels of salmonid alphavirus subtype 3 but not infectious pancreatic necrosis virus in vitro
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1401086
- 1,125 views
Original Research
Published on 06 Jun 2024
A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1387811
- 1,980 views
- 3 citations
Original Research
Published on 04 Jun 2024
The extracellular serine protease from Staphylococcus epidermidis elicits a type 2-biased immune response in atopic dermatitis patients
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1352704
- 2,110 views
Original Research
Published on 31 May 2024
The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1359380
- 997 views
Original Research
Published on 30 May 2024
Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individuals
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1394114
- 2,940 views
Original Research
Published on 28 May 2024
Immunization with PfGBP130 generates antibodies that inhibit RBC invasion by P. falciparum parasites
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1350560
- 1,304 views
Original Research
Published on 22 May 2024
Synthetic BSA-conjugated disaccharide related to the Streptococcus pneumoniae serotype 3 capsular polysaccharide increases IL-17A Levels, γδ T cells, and B1 cells in mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1388721
- 1,228 views
- 1 citation
Original Research
Published on 21 May 2024
Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1397579
- 1,979 views
- 1 citation
Brief Research Report
Published on 17 May 2024
Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1401728
- 2,444 views